Cargando…
Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
Lenvatinib is a tyrosine kinase receptor inhibitor used to treat unresectable hepatocellular carcinoma (HCC). In this study, we investigated the antitumor effects of Lenvatinib treatment on HCC cell lines. Proliferation was examined in four HCC cell lines (HuH-7, Hep3B, Li-7, and PLC/PRF/5) using Ce...
Autores principales: | Nakahara, Mai, Fujihara, Shintaro, Iwama, Hisakazu, Takuma, Kei, Oura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Morishita, Asahiro, Kobara, Hideki, Himoto, Takashi, Masaki, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468852/ https://www.ncbi.nlm.nih.gov/pubmed/36158319 http://dx.doi.org/10.3892/br.2022.1561 |
Ejemplares similares
-
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
por: Takuma, Kei, et al.
Publicado: (2022) -
Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells
por: Shi, Tingting, et al.
Publicado: (2021) -
Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
por: Morishita, Asahiro, et al.
Publicado: (2021) -
Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022) -
Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis
por: Shi, Tingting, et al.
Publicado: (2020)